We have a flat 20% off on all of our 2025 global market reports. And the coupon code is FY25SAVE
What is the current size and annual growth rate of the cardiac rhythm management (crm) devices and equipment market?
The cardiac rhythm management (CRM) devices and equipment market size has grown strongly in recent years. It will grow from $16.05 billion in 2024 to $17.15 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to prevalence of arrhythmias, technological advancements, aging population, chronic disease management.
The cardiac rhythm management (CRM) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $21.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to personalized medicine, technological innovations, telehealth integration, global access to healthcare. Major trends in the forecast period include leadless crm devices, biodegradable devices, remote monitoring, combination therapies.
Get Your Free Sample of The Global Cardiac Rhythm Management (CRM) Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2548&type=smp
Which major factors have contributed to the expansion of the cardiac rhythm management (crm) devices and equipment market?
The rise in the geriatric population is expected to propel the growth of the cardiac rhythm management (CRM) devices and equipment market going forward. The geriatric population refers to people aged 65 and over. With the increase in geriatric population, the incidence of cardiovascular diseases also rises, leading to an increased demand for CRM devices. These devices can help manage heart rhythm disorders, such as arrhythmias, and improve the quality of life for older adults. For instance, according to the Administration for Community Living, a US-based government department, the older population reached 55.8 million in 2021, and it is projected to reach 80.8 million by 2040 and 94.7 million by 2060. Thus, the rise in the geriatric population is driving the growth of the cardiac rhythm management (CRM) devices and equipment market.
How is the cardiac rhythm management (crm) devices and equipment market segmented?
The cardiac rhythm management (CRM) devices and equipment market covered in this report is segmented –
1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Physicians Clinics
Subsegment:
1) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Implantable Pacemakers
2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), External Defibrillators, Wearable Defibrillators, Automated External Defibrillators (AEDs)
3) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator), Bi-Ventricular Pacemakers
Order your report now for swift delivery
Who are the top competitors in the cardiac rhythm management (crm) devices and equipment market?
Major companies operating in the cardiac rhythm management (CRM) devices and equipment market include Abbott Laboratories, Medtronic plc, Biotronik SE & Co KG, Cardiac Science Corporation, Schiller AG, Hill-Rom Holdings Inc., GE Healthcare, Integer Holdings, Neovasc Inc., Philips Healthcare, Stryker Corporation, Rochling Medical, CCC Medical Devices, LivaNova plc, ZOLL Medical Corporation, Koninklijke Philips N.V, Applied Cardiac System, Cook Medical, Abiomed Inc., Berlin Heart GmbH, Brotionik SE and Co. KG, Jarvik Hearth Inc., MicroPort Scientific Corp, ReliantHeart Inc., Shree Pacetronix Ltd., Shaanxi Qinming Medical Instrument Co. Ltd., AtriCure Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, ProgettiSrl
Which key trends are expected to influence the cardiac rhythm management (crm) devices and equipment market in the coming years?
Major companies operating in the cardiac rhythm management (CRM) devices and equipment market are developing innovative products such as, single-chamber (VR) leadless pacemaker to manage heart rhythm disorders and improve patient outcomes, The leadless pacemaker is implanted directly inside the heart’s right ventricle via a minimally invasive procedure, eliminating the need for cardiac leads. For instance, in April 2022, Abbott Laboratories, a US-based medical device company received FDA approval for the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients with slow heart rhythms. The device can provide detailed insights into patient health and heart activity, which can inform treatment decisions and improve patient outcomes. The software for the Aveir VR leadless pacemaker was designed for expandability to a dual-chamber system, which can provide additional treatment options for patients in the future.
Which regional trends are influencing the cardiac rhythm management (crm) devices and equipment market, and which area dominates the industry?
North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2023. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market. The regions covered in the cardiac rhythm management (CRM) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Cardiac Rhythm Management (CRM) Devices And Equipment Market Report 2025 Offer?
The cardiac rhythm management (crm) devices and equipment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cardiac rhythm management (CRM) devices and equipment are used to manage the heart rate or rhythm by generating electrical impulses or shocks in order to get the heart back to its normal functions. CRM devices are used to treat and manage arrhythmia-related diseases such as cardiac arrests, heart failure, or cardiac arrhythmias.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2548
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
